The Official US Launch of Biolon OVD for Use in Cataract Surgery

July 17, 2018 Amring Pharmaceuticals Inc. (Amring), a generic pharmaceutical company, today announced the release of its latest product, Biolon OVD (ophthalmic viscosurgical device). Amring is excited to offer this new, cost-effective device and position itself in the...